Abstract
Over the last few years the intricate interaction between immunity and metabolism has been recognized. Indeed, it has been suggested that adipose tissue is not merely the site of energy storage, but can be considered as an “immune-related” organ producing a series of molecules named “adipocytokines.” Among these, leptin seems to play a pivotal role in the regulation of several neuroendocrine and immune functions. In this chapter, we describe the effects of leptin on innate/adaptive immunity and angiogenesis and speculate on the possible modulation of the leptin axis in novel therapeutic settings.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Y. Zhang, R. Proenca, M. Maffei, M. Barone, L. Leopold, and J. M. Friedman, Positional cloning of the mouse obese gene and its human homologue. Nature 372 (6505), 425–432 (1994).
F. Zhang, M, B. Basinski, J. M. Beals, S. L. Briggs, L. M. Churgay, D. K. Clawson, R. D. DiMarchi, T. C. Furman, J. E. Hale, H. M, Hsiung, B. E. Schoner, D, P. Smith, X. Y. Zhang, J. P. Wery, and R. W. Schevitz, Crystal structiu’e of the obese protein leptin-E100, Nature 387 (6629), 206–209 (1997).
B. D. Bennett, G. P. Solar, J. Q. Yuan, J. Mathias, G. R. Thomas, and W. Matthews, A role for leptin and its cognate receptor in hematopoiesis, Curr. Biol. 6 (9), 1170–1180 (1996).
G. M. Lord, G. Matarese, J. K. Howard, R. J. Baker, S. R. Bloom, and R. I. Lechler, Leptin modulates the T-cell immune response and reverses starvation-induced immunosuppression. Nature 394 (6696), 897–901 (1998).
L. A. Tartaglia, The leptin receptor, J. Biol. Chem. 272 (10), 6093–6100 (1997).
L. A. Tartaglia, M. Dembski, X. Weng, N. Deng, J. Culpepper, R. Devos, G. J. Richards, L. A. Campfield, F. T. Clark, J, Deeds, C. Muir, S. Sanker, A. Moriarty, K. J. Moore, J. S. Smutko, G. G. Mays, E. A. Wool, C. A. Monroe, and R. I. Tepper, Identification and expression cloning of a leptin receptor, OB-R, Cell. 83 (7), 1263–1271 (1995).
C. Martin-Romero, J. Santos-Alvarez, R. Goberna, and V. Sanchez-Margalet, Human leptin enhances activation and proliferation of human circulating T lymphocytes. Cell. Immunol. 199 (1), 15–24 (2000).
B. Siegmund, J. A. Sennello, J. Jones-Carson, F. Gamboni-Robertson, H. A. Lehr, A. Batra, L Fedke, M. Zeitz, and G. Fantuzzi, Leptin receptor expression on T lymphocytes modulates chronic intestinal inflammation in mice. Gut 53 (7), 965–972 (2004).
Y. Zhao, R. Sun, L. You, C. Gao, and Z. Tian, Expression of leptin receptors and response to leptin stimulation of human natural killer cell lines, Biochem. Biophys. Res. Commun. 300 (2), 247–252 (2003).
A. S. Banks, S. M. Davis, S. H. Bates, and M. G. Jr Myers, Activation of downstream signals by the long form of the leptin receptor, J. Biol. Chem. 275 (19), 14563–14572 (2000).
C. Bjorbaek, R. M. Buchholz, S. M. Davis, S. H. Bates, D. D. Pierroz, H. Gu, B. G. Neel, M. G. Jr Myers, and J. S. Flier, Divergent roles of SHP-2 in ERK activation by leptin receptors, J Biol. Chem. 276 (7), 4747–4755 (2001).
F. Caldefie-Chezet, A. Poulin, and M. P. Vasson, Leptin regulates functional capacities of polymorphonuclear neutrophils, Free Radic. Res. 37 (8), 809–814 (2003).
H. Zarkesh-Esfahani, A. G. Pockley, Z. Wu, P. G. Hellewell, A. P. Weetman, and R. J. Ross, Leptin indirectly activates human neutrophils via induction of TNF-alpha, J. Immunol. 172 (3), 1809–1814 (2004).
H. Zarkesh-Esfahani, G. Pockley, R. A. Metcalfe, M. Bidlingmaier, Z. Wu, A. Ajami, A. P. Weetman, C. J. Strasburger, and R. J. Ross, High-dose leptin activates human leukocytes via receptor expression on monocytes, J Immunol. 167 (8), 4593–4599 (2001).
Y. Zhao, R. Sun, L. You, C. Gao, and Z. Tian, Expression of leptin receptors and response to leptin stimulation of human natural killer cell lines, Biochem. Biophys. Res. Commun. 300 (2), 247–252 (2003).
J. K. Howard, G. M. Lord, G. Matarese, S. Vendetti, M, A. Ghatei, M. A. Ritter, R. I. Lechler, and S. R. Bloom, Leptin protects mice from starvation-induced lymphoid atrophy and increases thymic cellularity in ob/ob mice, J Clin. Invest. 104 (8), 1051–1059 (1999).
G. M. Lord, G. Matarese, J. K. Howard, and R. I. Lechler, The bioenergetics of the immune system, Science 292 (5518), 855–856 (2001).
J. M. Friedman, and J. L. Halaas, Leptin and the regulation of body weight in mammals, Nature, 395 (6704), 763–770 (1998).
R. Faggioni, J. Jones-Carson, D. A. Reed, C. A. Dinarello, K. R. Feingold, C. Grunfeld, and G. Fantuzzi, Leptin-deficient (ob/ob)mice are protected from T cell-mediated hepatotoxicity:role of tumor necrosis factor alpha and IL-18, Proc. Natl. Acad. Sci. USA 97 (5), 2367–2372 (2000).
N. Busso, A. So, V. Chobaz-Peclat, C. Morard, E. Martinez-Soria, D. Talabot-Ayer, and C. Gabay, Leptin signaling deficiency impairs humoral and cellular immune responses and attenuates experimental arthritis, J. Immunol. 168 (2), 875–882 (2002).
G. Matarese, A. Di Giacomo, V. Sanna, G. M. Lord, J. K. Howard, A. Di Tuoro, S. R. Bloom, R. I. Lechler, S. Zappacosta, and S. Fontana, Requirement for leptin in the induction and progression of autoimmune encephalomyelitis, J. Immunol 166 (10), 5909–5916 (2001).
V. Sanna, A. Di Giacomo, A. La Cava, R. I. Lechler, S. Fontana, S. Zappacosta, and G. Matarese, Leptin surge precedes onset of autoimmune encephalomyelitis and correlates with development of pathogenic T cell responses, J. Clin. Invest. 111 (2), 241–250 (2003).
G. Matarese, P. B. Carrieri, A. La Cava, F. Perna, V. Sanna, V. De Rosa, D. Aufiero, S. Fontana, and S. Zappacosta, Leptin increase in multiple sclerosis associates with reduced number of CD4(-H)CD25+regulatory T cells, Proc. Natl. Acad. ScL USA 102 (14), 5150–5155 (2005).
A. P. Batocchi, M. Rotondi, M. Caggiula, G. FrisuUo, F. Odoardi, V. Nociti, C. Carella, P. A. Tonali, and M. Mirabella, Leptin as a marker of multiple sclerosis activity in patients treated with interferon-beta, J Neuroimmunol 139 (1-2), 150–154 (2003).
B. Siegmund, H. A. Lehr, and G. Fantuzzi, Leptin:a pivotal mediator of intestinal inflammation in mice. Gastroenterology 122 (7), 2011–2025 (2002).
R. M. Tarzi, H. T. Cook, I. Jackson, C. D. Pusey, and G. M. Lord, Leptin-deficient mice are protected from accelerated nephrotoxic nephritis. Am. J. Pathol. 164 (2), 385–390 (2004).
G. Matarese, V. Sanna, R. I. Lechler, N. Sarvetnick, S. Fontana, S. Zappacosta, and A. La Cava, Leptin accelerates autoimmune diabetes in female NOD mice, Diabetes 51 (5), 1356–1361 (2002).
L, M. Gaetke, H. S, Oz, R. C. Frederich, and C. J. McClain, Anti-TNF-alpha antibody normalizes serum leptin in IL-2 deficient mice, J. Am. Coll Nutr. 22 (5), 415–420 (2003).
G. Matarese, V. Sanna, A. Di Giacomo, G. M. Lord, J. K. Howard, S, R. Bloom, R. L Lechler, S. Fontana, and S. Zappacosta, Leptin potentiates experimental autoimmune encephalomyelitis in SJL female mice and confers susceptibility to males, Eur. J. Immunol 31 (5), 1324–1332 (2001).
M. Klagsbrun, and P. A. D’Amore, Regulators of angiogenesis, Annu. Rev. Physiol. 53, 217–239 (1991).
J. Folkman, Angiogenesis and angiogenesis inhibition:an overview, EXS. 79, 1–8 (1997)
P. Bjorntorp, Adipose tissue distribution and function, Int. J. Obes. 2, 67–81 (1991).
Q. X. Zhang, C. J. Magovern, C. A. Mack, K. T. Budenbender, W. Ko, and T. K. Rosengart, Vascular endothelial growth factor is the major angiogenic factor in omentum:mechanism of the omentum-mediated angiogenesis, J. Surg. Res. 67 (2), 147–154 (1997).
A. Bouloumie, H. C. Drexler, M. Lafontan, and R. Busse R, Leptin, the product of Ob gene, promotes angiogenesis, Circ. Res. 83 (10), 1059–1066 (1998).
G. Uckaya, M. Ozata, Z. Bayraktar, V. Erten, N. Bingol, and I. C. Ozdemir, Is leptin associated with diabetic retinopathy? Diabetes Care. 23 (3), 371–376 (2000).
D. Hanahan, and R. A., Weinberg, The hallmarks of cancer. Cell. 100 (1), 57–70 (2000).
S. C. Campbell, O. V. Volpert, M. Ivanovich, and N. P. Bouck, Molecular mediators of angiogenesis in bladder cancer. Cancer Res. 58 (6), 1298–1304 (1998).
F. Bertolini, M. Paoiucci, F. Peccatori, S. Cinieri, A. Agazzi, P. F. Ferrucci, E. Cocorocchio, A. Goldhirsch, and G. Martinelli, Angiogenic growth factors and endostatin in non-Hodgkin’s lymphoma, Br. J. Haematol. 106 (2), 504–509 (1999).
L. Tessitore, B. Vizio, O. Jenkins, I. De Stefano, C. Ritossa, J. M. Argiles, C. Benedetto, and A. Mussa, Leptin expression in colorectal and breast cancer patients, Int. J. Mol. Med. 5 (4), 421–426 (2000).
L. Steinman, P. Conlon, R. Maki., and A. Foster, The intricate interplay among body weight, stress, and the immune response to friend or foe, J. Clin. Invest. 111 (2), 183–185 (2003).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2006 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Matarese, G., Procaccini, C., De Rosa, V. (2006). Leptin and Immune Function, Inflammation and Angiognenesis. In: Castracane, V.D., Henson, M.C. (eds) Leptin. Endocrine Updates, vol 25. Springer, Boston, MA. https://doi.org/10.1007/978-0-387-31416-7_7
Download citation
DOI: https://doi.org/10.1007/978-0-387-31416-7_7
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-387-31415-0
Online ISBN: 978-0-387-31416-7
eBook Packages: MedicineMedicine (R0)